UA106368C2 - 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators - Google Patents

1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators

Info

Publication number
UA106368C2
UA106368C2 UAA201112305A UAA201112305A UA106368C2 UA 106368 C2 UA106368 C2 UA 106368C2 UA A201112305 A UAA201112305 A UA A201112305A UA A201112305 A UAA201112305 A UA A201112305A UA 106368 C2 UA106368 C2 UA 106368C2
Authority
UA
Ukraine
Prior art keywords
medicaments
pyrazolo
pyrimidin
heterocyclyl
dihydro
Prior art date
Application number
UAA201112305A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Риккардо Джованнини
Корнелия Дорнер-Киоссек
Кристиан Айкмайер
Деннис Фиген
Томас Фокс
Клаус Фукс
Никлас Хайне
Хольгер Розенброк
Герхард Шенцле
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Priority claimed from PCT/EP2010/054050 external-priority patent/WO2010112437A1/en
Publication of UA106368C2 publication Critical patent/UA106368C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I), in which is a tetrahydropyranyl-group and Ris the group V-W-*, whereby V and W independently of each other may be an aryl group or an heteroaryl group, which independently of each other may optionally be substituted. According to one aspect of the invention the new compounds are for use as medicaments or for the manufacture of medicaments, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. The new compounds are also for the manufacture of medicaments and/or for use in the treatment of e.g. Alzheimer's disease, in particular for cognitive impairment associated with Alzheimer's disease.
UAA201112305A 2009-03-31 2010-03-26 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators UA106368C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
VE57409 2009-03-31
PCT/EP2010/054050 WO2010112437A1 (en) 2009-03-31 2010-03-26 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators

Publications (1)

Publication Number Publication Date
UA106368C2 true UA106368C2 (en) 2014-08-26

Family

ID=52681816

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201112305A UA106368C2 (en) 2009-03-31 2010-03-26 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators

Country Status (1)

Country Link
UA (1) UA106368C2 (en)

Similar Documents

Publication Publication Date Title
TN2011000493A1 (en) 1-heterocyclyl -1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin -4- one derivatives and their use as pde9a modulators
TN2013000324A1 (en) 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors
MY170189A (en) 6-cycloalkyl-1, 5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
HRP20182007T1 (en) 3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatment of respiratory diseases
MX347917B (en) Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof.
MY164274A (en) Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
WO2013077921A3 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
MY182670A (en) 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
MX2014010589A (en) PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE.
IL235659A (en) Substituted 3, 4 - dihydro-2h- pyrido [1, 2 - a] pyrazine -1, 6- dione derivatives useful for the treatment of (inter alia) alzheimer's disease
UA115887C2 (en) Amino-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
WO2012020848A8 (en) Heterocyclic compound and use thereof
NZ703111A (en) Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
MX340490B (en) Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators.
WO2015095337A3 (en) PYRAZOLO[1,5-a]PYRIMIDINECARBOXAMIDE DERIVATIVES FOR TREATING COGNITIVE IMPAIRMENT
SG195085A1 (en) Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
UA109459C2 (en) 5,6-Dihydroimidazo derivatives [1,2-a] Pyrazine-8-ylamine, Suitable as BACE-SECRETASE INHIBITORS (BACE)
NZ629499A (en) Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases
BR112012019302A2 (en) imidazo [1,2-b] [1,2,4] triazines as c-met inhibitors
MX339692B (en) Modulators of 5-ht receptors and methods of use thereof.
MY165623A (en) 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
UA106368C2 (en) 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
MY164134A (en) Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
WO2012138255A3 (en) Tricyclic derivatives of ν,ν'-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon
CY1115155T1 (en) 1-Heterocyclyl-1,5-dihydro-pyrazolo [3,4-D] pyrimidin-4-one derivative and their use as PDE9A modifiers